Abilis's non-invasive bladder cancer test shows Best-In-Class accuracy using a standard urine specimen needed by over 1,000,000 ppl/yr with symptoms.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free